Dr Satish Singh
Award Year: 2021 | Degree Year: 1981
Satish Singh obtained his B.Tech. Chemical Engineering from the IITD Delhi in 1981, and an M.S. and Ph.D. in Chemical Engineering from Kansas State University in 1983 and 1987 respectively.
Dr. Satish K Singh is currently the Vice President, Drug Product Development at Moderna Therapeutics. He has held a related position at Lonza Pharma and Biotech and was Research Fellow and Group Leader at Pfizer’s BioTherapeutics Pharmaceutical R&D unit prior to 2016. Satish has a long experience in the biopharma industry in product development activities and is an internationally recognized expert in all aspects of (bio)pharmaceutical Drug Product (biologics, vaccines) development. His experience includes ophthalmics and parenterals, encompassing primarily biologics but also small molecules, and he has been involved in the submission of several BLAs and INDs.
Satish has a strong technical background in (biological) drug product development, complemented by a deep understanding of regulatory challenges and the evolving regulatory landscape, and has more than 90 peer-reviewed scientific publications as well as several book chapters covering multiple topics. He is involved in various professional groups through the American Association of Pharmaceutical Scientists (AAPS) as well as several expert panels for the United States Pharmacopeia (USP). He was elected as a Fellow by the AAPS in 2018. His research interests also include the investigation of impact of freezing processes on proteins, use of computational approaches to mitigate develop-ability issues, protein aggregation and immunogenicity. He is a regular speaker at conferences, including a number in India as well as IITD, and intends to continue the post-career in a teaching mode, sharing his deep experience with a new generation of entrants in this field. In alignment with this interest, Satish holds the positions of Adjunct Professor at the Dept. of Physical Pharmaceutical Chemistry at Uppsala University, Sweden, and at School of Pharmacy, University of Michigan, Ann Arbor, USA.
A final word – the pandemic and the effort to bring a vaccine to commercialization in an historically unprecedented period of about 9 months could only have happened because the knowledge and experience for all the elements required was already there – the achievement was in making it happen in a few months instead of a few years, by prioritization of the core, laser focus on the goal, and last but not least, putting rest of life on hold.
In honoring Dr Satish Singh, IIT Delhi recognizes the outstanding contributions made by him in Research and Drug development. Through his achievements, Dr Singh has brought glory to the name of the Institute.
